Background: Community pharmacy appears to have undergone considerable change over the years.
Objectives: The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.
Methods: Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies. For each country, a factsheet on pharmacy services provided in 2023 and recent developments was populated based on a literature review and validated by country experts in community pharmacies. A semi-structured interview was conducted with a community pharmacist in all study countries to gather additional information, in particular on potential drivers for change.
Results: In all case study countries, community pharmacies offer a range of medicines-related and non-medicines-related services, ranging from core activities such as dispensing and counselling to information on general health topics, point-of-care testing, disposal of returned medicines and needle-exchange programs. Certain services are only permitted in some countries (e.g., vaccinations, generic substitution). Developments (e.g., additional tasks) were observed in the last decades, but some changes were only introduced recently in response to the pandemic (e.g., testing for COVID-19, COVID-19 vaccinations). Several, mostly facilitating, factors, such as high accessibility and acceptance of community pharmacies, the growing relevance of the primary health care concept and an appetite of community pharmacists to take over additional tasks, have contributed to changes in the range of services in community pharmacy in recent years and over the decades.
Conclusions: The study confirms changes in community pharmacy, with overall extension of the services offered. The COVID-19 pandemic was reported to have played an important role but was not considered the sole driver for change.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.sapharm.2025.03.001 | DOI Listing |
Res Social Adm Pharm
March 2025
Department of Primary Care and Medical Education, Institute of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. Electronic address:
Background: Deprescribing by physicians based on the suggestions of community pharmacists is useful to ensure medication safety. Pharmacist-led deprescribing is not always implemented smoothly because of communication gaps between physicians and pharmacists. Our previous study found that assertiveness, as a communication style, is associated with pharmacist-initiated prescription changes for medication safety; however, its association with community pharmacist-led deprescribing is unclear.
View Article and Find Full Text PDFRes Social Adm Pharm
March 2025
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Stubenring 6, 1010, Vienna, Austria; Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. Electronic address:
Background: Community pharmacy appears to have undergone considerable change over the years.
Objectives: The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.
Methods: Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies.
Keio J Med
March 2025
Division of Social Pharmacy, Center for Social Pharmacy and Pharmaceutical Care Sciences, Faculty of Pharmacy, Keio University, Tokyo, Japan.
Undernutrition is a common risk after surgery or during periods when oral dietary intake is challenging. Enteral nutrients, frequently utilized in nutritional management, are drugs associated with multiple contraindications involving pathology and allergy, and they require careful attention in dispensing. However, the occurrence of nutrition-related incidents in community pharmacies remains unknown.
View Article and Find Full Text PDFBJGP Open
March 2025
Department of clinical pharmacy, Canisius Wilhelmina Hospital, Utrecht University, Utrecht, The Netherlands
Background: Quetiapine, an antipsychotic, is registered for schizophrenia, bipolar disorder, and as an add-on therapy for major depressive disorder. Its anxiolytic and sedative effects make it attractive for off-label uses like insomnia, despite cardiovascular and metabolic side effects. The global increase in quetiapine use over the past decade warrants an examination of its prescribing patterns, especially off-label.
View Article and Find Full Text PDFJ Am Acad Dermatol
March 2025
Department of Dermatology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!